Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
BRIEF-Madrigal Pharmaceuticals Q2 Product Revenue USD 364.252 Million

BRIEF-Madrigal Pharmaceuticals Q2 Product Revenue USD 364.252 Million

ReutersReuters2026/07/30 11:01

Jul 30 (Reuters) - Madrigal Pharmaceuticals Q2 net income USD -57.939 million.

  • Q2 operating expenses USD 420.56 million
  • Q2 operating income USD -56.308 million
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!